Navigation Links
Immucor Appoints New Board Director
Date:12/16/2009

NORCROSS, Ga., Dec. 16 /PRNewswire-FirstCall/ -- Immucor, Inc. (Nasdaq: BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that Paul D. Mintz, M.D. has been appointed to its board as a new independent director, effective January 1, 2010.

Dr. Mintz has been involved in blood banking and transfusion medicine for more than 30 years. He is a tenured Professor of Pathology and Medicine at the University of Virginia School of Medicine. He also serves as director of the University of Virginia Health System's Clinical Laboratories and Transfusion Medicine Services as well as Chief of the Department of Pathology's Division of Clinical Pathology. Dr. Mintz is also a co-medical director of Virginia Blood Services.

Dr. Mintz has served on numerous national and regional boards and committees throughout his career for such agencies and organizations as the Centers for Medicare and Medicaid Services, the National Blood Foundation and the AABB (formerly the American Association of Blood Banks). He is a past president of AABB and served for several years on its FDA Advisory Committee, including as past chair.

"Paul is the chair of Immucor's Scientific Advisory Board, which provides scientific expertise and strategic counsel on a variety of scientific and technical issues," stated Joseph Rosen, Immucor's Chairman of the Board. "Paul's extensive experience in transfusion medicine and familiarity with Immucor make him a valuable addition to Immucor's Board of Directors."

Dr. Mintz was a recipient of a Transfusion Medicine Academic Award from the National Heart, Lung and Blood Institute. He has authored or co-authored more than 100 journal articles in blood banking and transfusion medicine.

Dr. Mintz will stand for regular election to a one-year term at the Company's next annual shareholders' meeting. The addition of Dr. Mintz expands the Company's board size to eight directors.

About Immucor

Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of its market segments. For more information on Immucor, please visit our website at www.immucor.com.

SOURCE Immucor, Inc.


'/>"/>
SOURCE Immucor, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Shareholder Class Action Filed Against Immucor, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
2. Immucor to Announce Fiscal First Quarter Financial Results on Thursday, October 1, 2009
3. Immucor to Present at Upcoming Investor Conferences
4. Immucor Announces Fiscal Fourth Quarter Results
5. Immucor Appoints Chief Operating Officer
6. Immucor Submits 10-Day Response to FDA; Establishes Product Surveillance and Improvement Department
7. Immucor to Announce Fiscal Fourth Quarter Financial Results on Thursday, July 23, 2009
8. Immucor Announces Fiscal Year 2010 Guidance
9. Immucor to Announce Fiscal 2010 Guidance on Monday, June 1, 2009
10. Immucor to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
11. Immucor Receives Subpoena From Department of Justice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 24, 2017 , ... “The Octagon of Spiritual Balances”: ... of Spiritual Balances” is the creation of published author, Pastor Bernard J. Weathers, pastor ... holds a bachelor degree in religious education and a master degree in theology. , ...
(Date:1/24/2017)... ... 23, 2017 , ... OSF Ventures, the corporate investment arm ... platform headquartered in Silicon Valley that connects startups to corporations and invests in ... three-year agreement to be a corporate sponsor of Plug and Play’s program for ...
(Date:1/24/2017)... ... January 23, 2017 , ... During the ... Carol Francis, Psychologist in the South Bay area , explained “Watching Women’s ... all people and by all people shines as a bright beacon of determination ...
(Date:1/23/2017)... , ... January 23, 2017 ... ... translation and localization services for life science companies, has achieved ISO 17100:2015 ... TÜV SÜD America. ISO 17100 is the globally recognized standard that establishes ...
(Date:1/23/2017)... ... January 23, 2017 , ... The Masters ... management and evaluation leaders with decades of experience who remain current practitioners in ... States healthcare system, there is a renewed demand for versatile, data-driven leadership.The American ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... 2017 7D Surgical announced today that ... U.S. Food and Drug Administration (FDA) and a ... North American commercial launch of its innovative Machine-vision ... the 7D Surgical System.  The ... and machine vision algorithms to eliminate the long-standing ...
(Date:1/23/2017)... and Markets has announced the addition of the "Needle Free Drug ... report to their offering. ... Highlights: The report provides a detailed analysis ... Market forecasts till 2025, using estimated market values as the ... Regions and Countries Key developments and strategies observed in ...
(Date:1/23/2017)... Alberta , January 23, 2017 ... del riñón (r enal) y ... sola dosis de a pabetalone    ... hoy los resultados preliminares de un ensayo en fase ... con discapacidad de riñón (renal) severa. Los datos demostraron ...
Breaking Medicine Technology: